Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.

The fatal immune dysregulation that sometimes follows EBV infection in boys has been linked to mutations in two X chromosome-encoded genes, SLAM-associated protein (SAP) and X-linked inhibitor of apoptosis (XIAP). In this study we describe 2 girls from a consanguineous Turkish family who died after...

Full description

Bibliographic Details
Main Authors: Huck, K, Feyen, O, Niehues, T, Rüschendorf, F, Hübner, N, Laws, H, Telieps, T, Knapp, S, Wacker, H, Meindl, A, Jumaa, H, Borkhardt, A
Format: Journal article
Language:English
Published: 2009
_version_ 1797063184009396224
author Huck, K
Feyen, O
Niehues, T
Rüschendorf, F
Hübner, N
Laws, H
Telieps, T
Knapp, S
Wacker, H
Meindl, A
Jumaa, H
Borkhardt, A
author_facet Huck, K
Feyen, O
Niehues, T
Rüschendorf, F
Hübner, N
Laws, H
Telieps, T
Knapp, S
Wacker, H
Meindl, A
Jumaa, H
Borkhardt, A
author_sort Huck, K
collection OXFORD
description The fatal immune dysregulation that sometimes follows EBV infection in boys has been linked to mutations in two X chromosome-encoded genes, SLAM-associated protein (SAP) and X-linked inhibitor of apoptosis (XIAP). In this study we describe 2 girls from a consanguineous Turkish family who died after developing severe immune dysregulation and therapy-resistant EBV-positive B cell proliferation following EBV infection. SNP array-based genome-wide linkage analysis revealed IL-2-inducible T cell kinase (ITK) as a candidate gene for this immunodeficiency syndrome. Both girls harbored a homozygous missense mutation that led to substitution of a highly conserved residue (R335W) in the SH2 domain of ITK. Characteristics of ITK deficiency in mouse models, such as absence of NKT cells and high levels of eomesodermin in CD8+ cells, were seen in either one or both of the girls. Two lines of evidence suggested that R335W caused instability of the ITK protein. First, in silico modeling of the mutant protein predicted destabilization of the SH2 domain. Additionally, Western blot analysis revealed that, unlike wild-type ITK, the R335W mutant was nearly undetectable when expressed in 293 T cells. Our results suggest that ITK deficiency causes what we believe to be a novel immunodeficiency syndrome that leads to a fatal inadequate immune response to EBV. Because ITK deficiency resembles EBV-associated lymphoproliferative disorders in boys, we suggest that this molecular cause should be considered during diagnosis and treatment.
first_indexed 2024-03-06T20:56:10Z
format Journal article
id oxford-uuid:3955b8c7-78ac-4588-85c2-ab6f1998808d
institution University of Oxford
language English
last_indexed 2024-03-06T20:56:10Z
publishDate 2009
record_format dspace
spelling oxford-uuid:3955b8c7-78ac-4588-85c2-ab6f1998808d2022-03-26T13:54:59ZGirls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3955b8c7-78ac-4588-85c2-ab6f1998808dEnglishSymplectic Elements at Oxford2009Huck, KFeyen, ONiehues, TRüschendorf, FHübner, NLaws, HTelieps, TKnapp, SWacker, HMeindl, AJumaa, HBorkhardt, AThe fatal immune dysregulation that sometimes follows EBV infection in boys has been linked to mutations in two X chromosome-encoded genes, SLAM-associated protein (SAP) and X-linked inhibitor of apoptosis (XIAP). In this study we describe 2 girls from a consanguineous Turkish family who died after developing severe immune dysregulation and therapy-resistant EBV-positive B cell proliferation following EBV infection. SNP array-based genome-wide linkage analysis revealed IL-2-inducible T cell kinase (ITK) as a candidate gene for this immunodeficiency syndrome. Both girls harbored a homozygous missense mutation that led to substitution of a highly conserved residue (R335W) in the SH2 domain of ITK. Characteristics of ITK deficiency in mouse models, such as absence of NKT cells and high levels of eomesodermin in CD8+ cells, were seen in either one or both of the girls. Two lines of evidence suggested that R335W caused instability of the ITK protein. First, in silico modeling of the mutant protein predicted destabilization of the SH2 domain. Additionally, Western blot analysis revealed that, unlike wild-type ITK, the R335W mutant was nearly undetectable when expressed in 293 T cells. Our results suggest that ITK deficiency causes what we believe to be a novel immunodeficiency syndrome that leads to a fatal inadequate immune response to EBV. Because ITK deficiency resembles EBV-associated lymphoproliferative disorders in boys, we suggest that this molecular cause should be considered during diagnosis and treatment.
spellingShingle Huck, K
Feyen, O
Niehues, T
Rüschendorf, F
Hübner, N
Laws, H
Telieps, T
Knapp, S
Wacker, H
Meindl, A
Jumaa, H
Borkhardt, A
Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
title Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
title_full Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
title_fullStr Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
title_full_unstemmed Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
title_short Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
title_sort girls homozygous for an il 2 inducible t cell kinase mutation that leads to protein deficiency develop fatal ebv associated lymphoproliferation
work_keys_str_mv AT huckk girlshomozygousforanil2inducibletcellkinasemutationthatleadstoproteindeficiencydevelopfatalebvassociatedlymphoproliferation
AT feyeno girlshomozygousforanil2inducibletcellkinasemutationthatleadstoproteindeficiencydevelopfatalebvassociatedlymphoproliferation
AT niehuest girlshomozygousforanil2inducibletcellkinasemutationthatleadstoproteindeficiencydevelopfatalebvassociatedlymphoproliferation
AT ruschendorff girlshomozygousforanil2inducibletcellkinasemutationthatleadstoproteindeficiencydevelopfatalebvassociatedlymphoproliferation
AT hubnern girlshomozygousforanil2inducibletcellkinasemutationthatleadstoproteindeficiencydevelopfatalebvassociatedlymphoproliferation
AT lawsh girlshomozygousforanil2inducibletcellkinasemutationthatleadstoproteindeficiencydevelopfatalebvassociatedlymphoproliferation
AT teliepst girlshomozygousforanil2inducibletcellkinasemutationthatleadstoproteindeficiencydevelopfatalebvassociatedlymphoproliferation
AT knapps girlshomozygousforanil2inducibletcellkinasemutationthatleadstoproteindeficiencydevelopfatalebvassociatedlymphoproliferation
AT wackerh girlshomozygousforanil2inducibletcellkinasemutationthatleadstoproteindeficiencydevelopfatalebvassociatedlymphoproliferation
AT meindla girlshomozygousforanil2inducibletcellkinasemutationthatleadstoproteindeficiencydevelopfatalebvassociatedlymphoproliferation
AT jumaah girlshomozygousforanil2inducibletcellkinasemutationthatleadstoproteindeficiencydevelopfatalebvassociatedlymphoproliferation
AT borkhardta girlshomozygousforanil2inducibletcellkinasemutationthatleadstoproteindeficiencydevelopfatalebvassociatedlymphoproliferation